Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values SLC45A1 50651 broad.mit.edu 37 1 8395553 8395553 + Silent SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:8395553C>T uc001apb.3 + 4 1500 c.1500C>T c.(1498-1500)agC>agT p.S500S SLC45A1_uc001apc.3_Silent_p.S198S NM_001080397 NP_001073866 Q9Y2W3 S45A1_HUMAN Homo sapiens solute carrier family 45, member 1 (SLC45A1), mRNA. 500 carbohydrate transport integral to membrane symporter activity central_nervous_system(2)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|liver(1)|lung(12)|ovary(2)|pancreas(2)|prostate(4)|skin(2)|urinary_tract(2) 33 Ovarian(185;0.0661)|all_lung(157;0.127) all_epithelial(116;1.22e-15)|all_lung(118;0.000147)|Lung NSC(185;0.000251)|Renal(390;0.000469)|Colorectal(325;0.00578)|Breast(348;0.00686)|Hepatocellular(190;0.0228)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.11) UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|all cancers(8;3.95e-66)|GBM - Glioblastoma multiforme(8;5.93e-33)|Colorectal(212;2.86e-07)|COAD - Colon adenocarcinoma(227;3.11e-05)|Kidney(185;5.33e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000513)|KIRC - Kidney renal clear cell carcinoma(229;0.000979)|STAD - Stomach adenocarcinoma(132;0.00199)|READ - Rectum adenocarcinoma(331;0.0649) CGGGCTCCAGCGAGCGCGCGG 0.647 ST6GALNAC3 256435 broad.mit.edu 37 1 77094323 77094323 + Missense_Mutation SNP A A T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:77094323A>T uc001dhh.2 + 4 913 c.750A>T c.(748-750)aaA>aaT p.K250N ST6GALNAC3_uc010orh.1_Missense_Mutation_p.K149N NM_152996 NP_694541 Q8NDV1 SIA7C_HUMAN Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3), transcript variant 1, mRNA. 250 protein glycosylation integral to Golgi membrane sialyltransferase activity breast(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(20)|ovary(3)|prostate(1)|skin(2) 36 GGTATAGAAAAGTCCCCTACC 0.363 HCN3 57657 broad.mit.edu 37 1 155254428 155254428 + Silent SNP C C G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:155254428C>G uc001fjz.1 + 3 977 c.969C>G c.(967-969)ccC>ccG p.P323P HCN3_uc010pfz.1_Intron NM_020897 NP_065948 Q9P1Z3 HCN3_HUMAN Homo sapiens hyperpolarization activated cyclic nucleotide-gated potassium channel 3 (HCN3), mRNA. 323 integral to membrane cAMP binding|sodium channel activity|voltage-gated potassium channel activity p.P323L(1) breast(1)|central_nervous_system(1)|endometrium(4)|kidney(3)|large_intestine(5)|lung(10)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 27 all_lung(78;2.32e-23)|Hepatocellular(266;0.0877)|all_hematologic(923;0.088) Epithelial(20;3.72e-10)|all cancers(21;1.19e-09)|BRCA - Breast invasive adenocarcinoma(34;0.000752)|LUSC - Lung squamous cell carcinoma(543;0.193) TAGGCATGCCCGACGTCTGGC 0.597 CD1B 910 broad.mit.edu 37 1 158300836 158300836 + Silent SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:158300836G>A uc001frx.3 - 1 186 c.78C>T c.(76-78)acC>acT p.T26T CD1B_uc001frw.3_Silent_p.T26T|CD1B_uc010pic.1_Silent_p.T26T NM_001764 NP_001755 P29016 CD1B_HUMAN Homo sapiens CD1b molecule (CD1B), mRNA. 26 antigen processing and presentation|immune response endosome membrane|integral to membrane|lysosomal membrane|plasma membrane protein binding breast(2)|large_intestine(2)|lung(17)|ovary(2)|prostate(5)|skin(1)|upper_aerodigestive_tract(1) 30 all_hematologic(112;0.0378) CATGAAAGGAGGTCGGCCCCT 0.458 VSIG8 391123 broad.mit.edu 37 1 159827989 159827989 + Nonsense_Mutation SNP G G C rs138280068 TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:159827989G>C uc001fuh.3 - 2 457 c.321C>G c.(319-321)taC>taG p.Y107* VSIG8_uc001fug.1_5'Flank NM_001013661 NP_001013683 Q5VU13 VSIG8_HUMAN Homo sapiens V-set and immunoglobulin domain containing 8 (VSIG8), mRNA. 107 Ig-like V-type 1. integral to membrane central_nervous_system(1)|kidney(1)|large_intestine(3)|lung(1)|prostate(1)|upper_aerodigestive_tract(1) 8 all_hematologic(112;0.0597) TGGAGGCATCGTACTGGCTTG 0.542 ITLN2 142683 broad.mit.edu 37 1 160920979 160920979 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:160920979C>T uc001fxd.3 - 3 353 c.295G>A c.(295-297)Gag>Aag p.E99K ITLN2_uc009wts.3_Missense_Mutation_p.E98K|ITLN2_uc010pju.2_Missense_Mutation_p.E16K NM_080878 NP_543154 Q8WWU7 ITLN2_HUMAN Homo sapiens intelectin 2 (ITLN2), mRNA. 99 Fibrinogen C-terminal. signal transduction extracellular region receptor binding|sugar binding endometrium(4)|large_intestine(4)|lung(5)|ovary(1)|pancreas(1)|skin(2)|stomach(1)|urinary_tract(1) 19 all_cancers(52;2.99e-17)|all_hematologic(112;0.093) BRCA - Breast invasive adenocarcinoma(70;0.00275) ATGTCATTCTCGTGCACGCTG 0.582 LAMC2 3918 broad.mit.edu 37 1 183207550 183207550 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr1:183207550C>T uc001gqa.2 + 18 3177 c.2863C>T c.(2863-2865)Ctc>Ttc p.L955F LAMC2_uc001gpz.4_Missense_Mutation_p.L955F|LAMC2_uc010poa.2_Missense_Mutation_p.L655F NM_005562 NP_005553 Q13753 LAMC2_HUMAN Homo sapiens laminin, gamma 2 (LAMC2), transcript variant 1, mRNA. 955 Domain II and I. cell adhesion|epidermis development|hemidesmosome assembly heparin binding breast(2)|endometrium(6)|kidney(8)|large_intestine(11)|lung(18)|ovary(1)|skin(5)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 55 CCTTAAAAACCTCAGAGGTTA 0.413 ITGA8 8516 broad.mit.edu 37 10 15590502 15590502 + Silent SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr10:15590502G>A uc001ioc.1 - 26 2832 c.2832C>T c.(2830-2832)agC>agT p.S944S ITGA8_uc010qcb.1_Silent_p.S929S NM_003638 NP_003629 P53708 ITA8_HUMAN Homo sapiens integrin, alpha 8 (ITGA8), mRNA. 944 cell differentiation|cell-cell adhesion|cell-matrix adhesion|integrin-mediated signaling pathway|nervous system development integrin complex receptor activity NS(2)|breast(1)|cervix(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(10)|lung(57)|ovary(3)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(3) 96 TCAGGACTGCGCTTTCTCCTC 0.483 PLCE1 51196 broad.mit.edu 37 10 95791394 95791394 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr10:95791394G>A uc001kjk.3 + 1 1225 c.591G>A c.(589-591)atG>atA p.M197I PLCE1_uc010qnx.2_Missense_Mutation_p.M197I NM_016341 NP_057425 Q9P212 PLCE1_HUMAN Homo sapiens phospholipase C, epsilon 1 (PLCE1), transcript variant 1, mRNA. 197 activation of MAPK activity|activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger|activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway|calcium-mediated signaling|cell proliferation|cytoskeleton organization|diacylglycerol biosynthetic process|elevation of cytosolic calcium ion concentration|epidermal growth factor receptor signaling pathway|glomerulus development|heart development|lipid catabolic process|Ras protein signal transduction|regulation of cell growth|regulation of G-protein coupled receptor protein signaling pathway|regulation of Ras protein signal transduction|regulation of smooth muscle contraction cytosol|Golgi membrane|membrane fraction|plasma membrane calcium ion binding|guanyl-nucleotide exchange factor activity|phosphatidylinositol phospholipase C activity|Ras GTPase binding|receptor signaling protein activity liver(1)|ovary(2)|skin(4)|upper_aerodigestive_tract(1) 8 Colorectal(252;0.0458) ACAGAAGAATGTCAGACACTT 0.408 KIAA1598 57698 broad.mit.edu 37 10 118689505 118689505 + Missense_Mutation SNP T T A rs145640256 TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr10:118689505T>A uc021pzk.1 - 9 1365 c.867A>T c.(865-867)gaA>gaT p.E289D KIAA1598_uc009xyw.3_Missense_Mutation_p.E289D|KIAA1598_uc001lcz.4_Missense_Mutation_p.E289D|KIAA1598_uc010qso.2_Missense_Mutation_p.E229D|KIAA1598_uc010qsp.1_Missense_Mutation_p.E289D|KIAA1598_uc010qsq.1_Missense_Mutation_p.E229D|KIAA1598_uc001lcy.4_Missense_Mutation_p.E259D NM_018330 NP_060800 A0MZ66 SHOT1_HUMAN Homo sapiens KIAA1598 (KIAA1598), transcript variant 2, mRNA. 289 axon guidance axon endometrium(1)|kidney(1)|large_intestine(5)|lung(3) 10 all cancers(201;0.00494) GCTCTTCTAATTCTTTGACCT 0.308 OR5D16 390144 broad.mit.edu 37 11 55606593 55606593 + Nonsense_Mutation SNP T T A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr11:55606593T>A uc010rio.2 + 0 366 c.366T>A c.(364-366)taT>taA p.Y122* NM_001005496 NP_001005496 Q8NGK9 OR5DG_HUMAN Homo sapiens olfactory receptor, family 5, subfamily D, member 16 (OR5D16), mRNA. 122 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity cervix(1)|endometrium(2)|large_intestine(4)|lung(26)|ovary(5)|prostate(2)|skin(3)|upper_aerodigestive_tract(1) 44 all_epithelial(135;0.208) TGATGGCCTATGACCACTTTG 0.433 LRRIQ1 84125 broad.mit.edu 37 12 85466877 85466877 + Splice_Site SNP G G T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr12:85466877G>T uc001tac.3 + 11 2998 c.2887_splice c.e11+1 p.C963_splice LRRIQ1_uc021rbo.1_Splice_Site_p.C841_splice NM_001079910 NP_001073379 Q96JM4 LRIQ1_HUMAN Homo sapiens leucine-rich repeats and IQ motif containing 1 (LRRIQ1), mRNA. 963 breast(1)|central_nervous_system(1)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(21)|liver(1)|lung(28)|ovary(5)|prostate(1)|skin(8)|stomach(2)|upper_aerodigestive_tract(2) 83 GBM - Glioblastoma multiforme(134;0.212) TACTGGAATTGTAAGttgtgt 0.358 NOS1 4842 broad.mit.edu 37 12 117723943 117723943 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr12:117723943C>T uc001twn.2 - 5 1967 c.1256G>A c.(1255-1257)cGc>cAc p.R419H NOS1_uc021ren.1_Missense_Mutation_p.R83H|NOS1_uc021reo.1_Missense_Mutation_p.R83H|NOS1_uc001twm.2_Missense_Mutation_p.R419H NM_001204218 NP_001191147 P29475 NOS1_HUMAN Homo sapiens nitric oxide synthase 1 (neuronal) (NOS1), transcript variant 2, mRNA. 419 multicellular organismal response to stress|myoblast fusion|negative regulation of calcium ion transport into cytosol|neurotransmitter biosynthetic process|nitric oxide biosynthetic process|platelet activation|positive regulation of vasodilation|regulation of cardiac muscle contraction|response to heat|response to hypoxia cytoskeleton|cytosol|dendritic spine|perinuclear region of cytoplasm|photoreceptor inner segment|sarcolemma|sarcoplasmic reticulum arginine binding|cadmium ion binding|calmodulin binding|flavin adenine dinucleotide binding|FMN binding|heme binding|NADP binding|nitric-oxide synthase activity|tetrahydrobiopterin binding NS(1)|breast(1)|central_nervous_system(3)|endometrium(11)|haematopoietic_and_lymphoid_tissue(1)|kidney(17)|large_intestine(21)|lung(43)|ovary(3)|pancreas(1)|prostate(6)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1) 117 all_neural(191;0.0804)|Medulloblastoma(191;0.0922) BRCA - Breast invasive adenocarcinoma(302;0.0561) L-Citrulline(DB00155) GCCCACACAGCGCGAGGCATT 0.557 ACADS 35 broad.mit.edu 37 12 121164991 121164991 + Missense_Mutation SNP A A G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr12:121164991A>G uc001tza.4 + 2 328 c.210_splice c.e2+1 p.Q70_splice ACADS_uc010szl.1_Splice_Site_p.Q70_splice NM_000017 NP_000008 P16219 ACADS_HUMAN Homo sapiens acyl-CoA dehydrogenase, C-2 to C-3 short chain (ACADS), nuclear gene encoding mitochondrial protein, mRNA. 70 mitochondrial matrix butyryl-CoA dehydrogenase activity central_nervous_system(3)|endometrium(1)|kidney(1)|large_intestine(1)|lung(5)|prostate(3) 14 all_neural(191;0.0684)|Medulloblastoma(191;0.0922) Lung NSC(355;0.163) NADH(DB00157) CCAGCGGCTCAGGTGAGAGTG 0.567 RB1 5925 broad.mit.edu 37 13 49039379 49039379 + Silent SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr13:49039379C>T uc001vcb.3 + 22 2530 c.2364C>T c.(2362-2364)agC>agT p.S788S NM_000321 NP_000312 P06400 RB_HUMAN Homo sapiens retinoblastoma 1 (RB1), mRNA. 788 Domain C; mediates interaction with E4F1.|Interaction with LIMD1. androgen receptor signaling pathway|cell cycle arrest|chromatin remodeling|G1 phase of mitotic cell cycle|interspecies interaction between organisms|maintenance of mitotic sister chromatid cohesion|mitotic cell cycle G1/S transition checkpoint|myoblast differentiation|negative regulation of cell growth|negative regulation of protein kinase activity|negative regulation of S phase of mitotic cell cycle|negative regulation of sequence-specific DNA binding transcription factor activity|positive regulation of mitotic metaphase/anaphase transition|protein localization to chromosome, centromeric region|Ras protein signal transduction|regulation of centromere complex assembly|regulation of cohesin localization to chromatin|regulation of lipid kinase activity|regulation of transcription involved in G1/S phase of mitotic cell cycle|S phase of mitotic cell cycle|sister chromatid biorientation chromatin|PML body|Rb-E2F complex|SWI/SNF complex androgen receptor binding|DNA binding|kinase binding|phosphoprotein binding|sequence-specific DNA binding transcription factor activity|transcription coactivator activity|transcription factor binding|ubiquitin protein ligase binding p.0?(15)|p.?(11)|p.R787*(4) NS(3)|adrenal_gland(1)|bone(22)|breast(30)|central_nervous_system(48)|cervix(3)|endometrium(14)|eye(95)|gastrointestinal_tract_(site_indeterminate)(1)|haematopoietic_and_lymphoid_tissue(20)|kidney(3)|large_intestine(10)|liver(3)|lung(153)|oesophagus(1)|ovary(13)|pancreas(5)|pituitary(1)|prostate(14)|salivary_gland(2)|skin(9)|soft_tissue(9)|stomach(4)|upper_aerodigestive_tract(1)|urinary_tract(31) 496 all_cancers(8;6.9e-71)|all_epithelial(8;4.61e-22)|Acute lymphoblastic leukemia(8;1.1e-21)|all_hematologic(8;2.3e-21)|all_lung(13;1.51e-09)|Lung NSC(96;7.03e-07)|Breast(56;1.53e-05)|Prostate(109;0.000493)|Myeloproliferative disorder(33;0.0179)|Hepatocellular(98;0.0207)|all_neural(104;0.0227)|Glioma(44;0.0286)|Lung SC(185;0.0301) GBM - Glioblastoma multiforme(2;9.98e-18)|LUSC - Lung squamous cell carcinoma(3;0.013) Insulin Glargine recombinant(DB00047)|Insulin Lyspro recombinant(DB00046)|Insulin recombinant(DB00030)|Insulin, porcine(DB00071) TTCCTCGAAGCCCTTACAAGT 0.403 6 """D, Mis, N, F, S""" """retinoblastoma, sarcoma, breast, small cell lung""" """retinoblastoma, sarcoma, breast, small cell lung""" Hereditary Retinoblastoma TCGA GBM(7;6.82e-08)|TSP Lung(12;0.097)|TCGA Ovarian(6;0.080) BORA 79866 broad.mit.edu 37 13 73321201 73321201 + Silent SNP A A G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr13:73321201A>G uc010aen.1 + 9 1806 c.1659A>G c.(1657-1659)tcA>tcG p.S553S BORA_uc010thq.1_Silent_p.S253S|BORA_uc001viv.1_Silent_p.S478S|BORA_uc010thr.1_Silent_p.S408S NM_024808 NP_079084 Q6PGQ7 BORA_HUMAN Homo sapiens bora, aurora kinase A activator (BORA), mRNA. 478 cell division|mitosis|regulation of mitosis|regulation of mitotic spindle organization|regulation of protein localization protein kinase binding TGTGCATGTCACCTCTTGCTG 0.413 PYGO1 26108 broad.mit.edu 37 15 55838924 55838927 + Frame_Shift_Del DEL TGAC TGAC - TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr15:55838924_55838927delTGAC uc002adf.1 - 2 554_557 c.554_557delGTCA c.(553-558)agtcaafs p.S185fs PYGO1_uc010bfl.1_Frame_Shift_Del_p.S185fs NM_015617 NP_056432 Q9Y3Y4 PYGO1_HUMAN Homo sapiens pygopus homolog 1 (Drosophila) (PYGO1), mRNA. 185 Asn-rich. Wnt receptor signaling pathway nucleus zinc ion binding endometrium(4)|kidney(2)|large_intestine(6)|lung(6)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(3) 27 all cancers(107;0.0131)|GBM - Glioblastoma multiforme(80;0.18) TGGAGGAATTTGACTGAAATTTTC 0.333 MAPK3 5595 broad.mit.edu 37 16 30128054 30128054 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr16:30128054G>A uc002dws.3 - 7 1175 c.1075C>T c.(1075-1077)Cgg>Tgg p.R359W BOLA2_uc010bzb.1_Intron|MAPK3_uc002dwr.3_Missense_Mutation_p.R245W|MAPK3_uc002dwv.4_Missense_Mutation_p.R315W|MAPK3_uc002dwt.3_3'UTR NM_002746 NP_002737 P27361 MK03_HUMAN Homo sapiens mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, mRNA. 359 activation of MAPK activity|activation of MAPKK activity|axon guidance|cell cycle|cellular response to mechanical stimulus|epidermal growth factor receptor signaling pathway|innate immune response|insulin receptor signaling pathway|interleukin-1-mediated signaling pathway|interspecies interaction between organisms|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|nerve growth factor receptor signaling pathway|platelet activation|positive regulation of histone acetylation|positive regulation of histone phosphorylation|positive regulation of transcription from RNA polymerase II promoter|Ras protein signal transduction|regulation of sequence-specific DNA binding transcription factor activity|stress-activated MAPK cascade|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|transcription initiation from RNA polymerase I promoter cytosol|nucleoplasm ATP binding|MAP kinase activity|phosphatase binding p.R359W(1) Arsenic trioxide(DB01169)|Isoproterenol(DB01064)|Simvastatin(DB00641)|Sulindac(DB00605) TCCTTCAGCCGCTCCTTAGGT 0.642 SLC12A3 6559 broad.mit.edu 37 16 56913524 56913524 + Missense_Mutation SNP C C T rs139743444 byFrequency TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr16:56913524C>T uc002ekd.4 + 10 1435 c.1406C>T c.(1405-1407)gCc>gTc p.A469V SLC12A3_uc010ccm.3_Missense_Mutation_p.A469V|SLC12A3_uc010ccn.3_Missense_Mutation_p.A468V NM_000339 NP_000330 P55017 S12A3_HUMAN Homo sapiens solute carrier family 12 (sodium/chloride transporters), member 3 (SLC12A3), transcript variant 1, mRNA. 469 sodium ion transmembrane transport apical plasma membrane|integral to plasma membrane|membrane fraction sodium:chloride symporter activity breast(1)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(7)|lung(28)|ovary(2)|prostate(1)|skin(1)|stomach(1)|urinary_tract(1) 50 Bendroflumethiazide(DB00436)|Benzthiazide(DB00562)|Chlorothiazide(DB00880)|Diazoxide(DB01119)|Hydrochlorothiazide(DB00999)|Metolazone(DB00524)|Polythiazide(DB01324)|Quinethazone(DB01325) CTCTCCTCTGCCCTGGCCTGC 0.632 C17orf85 55421 broad.mit.edu 37 17 3721586 3721586 + Silent SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:3721586G>A uc010ckl.1 - 9 1304 c.1281C>T c.(1279-1281)gaC>gaT p.D427D C17orf85_uc002fwr.2_Silent_p.D137D|C17orf85_uc002fwq.2_Silent_p.D147D NM_001114118 NP_061023 Q53F19 CQ085_HUMAN Homo sapiens chromosome 17 open reading frame 85 (C17orf85), mRNA. 427 nucleotide binding endometrium(2)|large_intestine(2)|lung(4)|skin(1)|urinary_tract(1) 10 UCEC - Uterine corpus endometrioid carcinoma (3;0.0725) ATTCCACTTCGTCAGCATACA 0.328 TP53 7157 broad.mit.edu 37 17 7577551 7577551 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:7577551C>T uc002gim.2 - 6 924 c.730G>A c.(730-732)Ggc>Agc p.G244S TP53_uc002gig.1_Missense_Mutation_p.G244S|TP53_uc002gih.3_Missense_Mutation_p.G244S|TP53_uc010cne.1_5'Flank|TP53_uc010cng.1_Missense_Mutation_p.G112S|TP53_uc010cnf.1_Missense_Mutation_p.G112S|TP53_uc002gii.1_Missense_Mutation_p.G112S|TP53_uc010cni.1_Missense_Mutation_p.G244S|TP53_uc010cnh.1_Missense_Mutation_p.G244S|TP53_uc002gij.2_Missense_Mutation_p.G244S|TP53_uc010cnj.1_Non-coding_Transcript|TP53_uc002gin.2_Missense_Mutation_p.G151S|TP53_uc002gio.2_Missense_Mutation_p.G112S|DL476309_uc021tpg.1_5'Flank|DL476358_uc021tph.1_5'Flank NM_001126112 NP_001119587 P04637 P53_HUMAN Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA. 244 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain. G -> A (in sporadic cancers; somatic mutation).|G -> C (in sporadic cancers; somatic mutation).|G -> D (in LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs28934572).|G -> E (in a sporadic cancer; somatic mutation).|G -> R (in sporadic cancers; somatic mutation).|G -> S (in sporadic cancers; somatic mutation).|G -> V (in LFS; germline mutation and in sporadic cancers; somatic mutation).|MG -> IC (in a sporadic cancer; somatic mutation).|MG -> IS (in a sporadic cancer; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.G244C(82)|p.G244S(75)|p.G244D(42)|p.G244V(14)|p.G244G(13)|p.M243L(10)|p.G244R(10)|p.G244fs*3(9)|p.G244A(9)|p.0?(8)|p.M243I(7)|p.M243T(5)|p.?(5)|p.G151C(4)|p.G244fs*4(4)|p.M243V(3)|p.G244fs*19(2)|p.G244fs*17(2)|p.C242_M246>L(2)|p.C238_M246delCNSSCMGGM(2)|p.M243K(2)|p.M243R(2)|p.G244del(2)|p.M243fs*18(2)|p.M243_G244>IC(2)|p.S241_G245delSCMGG(2)|p.G244_M246del(1)|p.Y236_M243delYMCNSSCM(1)|p.G151R(1)|p.G151S(1)|p.G151fs*4(1)|p.G244_M246>V(1)|p.M243fs*4(1)|p.C242fs*98(1)|p.G244E(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) TTCATGCCGCCCATGCAGGAA 0.582 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) TP53 7157 broad.mit.edu 37 17 7578464 7578464 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:7578464G>A uc002gim.2 - 4 660 c.466C>T c.(466-468)Cgc>Tgc p.R156C TP53_uc002gig.1_Missense_Mutation_p.R156C|TP53_uc002gih.3_Missense_Mutation_p.R156C|TP53_uc010cne.1_5'Flank|TP53_uc010cng.1_Missense_Mutation_p.R24C|TP53_uc010cnf.1_Missense_Mutation_p.R24C|TP53_uc002gii.1_Missense_Mutation_p.R24C|TP53_uc010cni.1_Missense_Mutation_p.R156C|TP53_uc010cnh.1_Missense_Mutation_p.R156C|TP53_uc002gij.2_Missense_Mutation_p.R156C|TP53_uc010cnj.1_Non-coding_Transcript|TP53_uc002gin.2_Missense_Mutation_p.R63C|TP53_uc002gio.2_Missense_Mutation_p.R24C|TP53_uc010vug.2_Missense_Mutation_p.R117C NM_001126112 NP_001119587 P04637 P53_HUMAN Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA. 156 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. R -> C (in sporadic cancers; somatic mutation).|R -> G (in sporadic cancers; somatic mutation).|R -> H (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in sporadic cancers; somatic mutation).|R -> S (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R156P(24)|p.R156fs*14(20)|p.T155N(20)|p.T155P(16)|p.T155I(12)|p.R156H(10)|p.0?(8)|p.T155A(8)|p.R156S(6)|p.R156G(6)|p.?(5)|p.R156fs*25(5)|p.T155T(5)|p.R156_I162delRVRAMAI(4)|p.T155fs*23(4)|p.P152fs*14(4)|p.R156C(4)|p.R156R(3)|p.R156L(3)|p.T155_R156delTR(2)|p.R156_A161delRVRAMA(2)|p.P151_V173del23(2)|p.R156del(2)|p.G154fs*14(2)|p.R156_R158delRVR(2)|p.R156fs*12(2)|p.R156fs*18(2)|p.R156_A161del(2)|p.P153fs*22(2)|p.R156_V157del(2)|p.T155_A161delTRVRAMA(2)|p.G154_R156delGTR(2)|p.T155S(2)|p.T155fs*26(1)|p.T155fs*25(1)|p.D148_T155delDSTPPPGT(1)|p.D148fs*23(1)|p.S149fs*72(1)|p.R156fs*?(1)|p.G154fs*22(1)|p.T155_R156insDSTPPPGT(1)|p.T155fs*15(1)|p.R156fs*20(1)|p.R156_V157insV(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GCGCGGACGCGGGTGCCGGGC 0.612 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) TP53 7157 broad.mit.edu 37 17 7578466 7578466 + Missense_Mutation SNP G G T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:7578466G>T uc002gim.2 - 4 658 c.464C>A c.(463-465)aCc>aAc p.T155N TP53_uc002gig.1_Missense_Mutation_p.T155N|TP53_uc002gih.3_Missense_Mutation_p.T155N|TP53_uc010cne.1_5'Flank|TP53_uc010cng.1_Missense_Mutation_p.T23N|TP53_uc010cnf.1_Missense_Mutation_p.T23N|TP53_uc002gii.1_Missense_Mutation_p.T23N|TP53_uc010cni.1_Missense_Mutation_p.T155N|TP53_uc010cnh.1_Missense_Mutation_p.T155N|TP53_uc002gij.2_Missense_Mutation_p.T155N|TP53_uc010cnj.1_Non-coding_Transcript|TP53_uc002gin.2_Missense_Mutation_p.T62N|TP53_uc002gio.2_Missense_Mutation_p.T23N|TP53_uc010vug.2_Missense_Mutation_p.T116N NM_001126112 NP_001119587 P04637 P53_HUMAN Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA. 155 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. T -> A (in sporadic cancers; somatic mutation).|T -> I (in sporadic cancers; somatic mutation).|T -> M (in a sporadic cancer; somatic mutation).|T -> N (in LFS; germline mutation and in sporadic cancers; somatic mutation).|T -> P (in sporadic cancers; somatic mutation).|T -> S (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.T155N(42)|p.G154V(41)|p.T155I(26)|p.T155P(16)|p.G154G(12)|p.G154S(9)|p.T155A(8)|p.0?(8)|p.G154D(6)|p.?(5)|p.T155T(5)|p.G154fs*14(4)|p.T155fs*23(4)|p.P152fs*14(4)|p.G154I(3)|p.G154fs*27(3)|p.T155S(3)|p.P151_V173del23(2)|p.G154fs*16(2)|p.G154_R156delGTR(2)|p.G154C(2)|p.T155fs*25(2)|p.D148_T155delDSTPPPGT(2)|p.P153fs*22(2)|p.T155_A161delTRVRAMA(2)|p.G154fs*22(2)|p.T155_R156delTR(2)|p.T155fs*26(1)|p.R156_A161del(1)|p.G154A(1)|p.D148fs*23(1)|p.Q144_G154del11(1)|p.S149fs*72(1)|p.T23N(1)|p.T62N(1)|p.T62I(1)|p.T23I(1)|p.T155_R156insDSTPPPGT(1)|p.T155fs*15(1)|p.R156fs*25(1)|p.P153_G154insX(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GCGGACGCGGGTGCCGGGCGG 0.612 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) ALOX15B 247 broad.mit.edu 37 17 7942479 7942479 + Silent SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:7942479C>T uc002gju.3 + 0 122 c.6C>T c.(4-6)gcC>gcT p.A2A ALOX15B_uc002gjv.3_Silent_p.A2A|ALOX15B_uc002gjw.3_Silent_p.A2A|ALOX15B_uc010vun.2_Silent_p.A2A|ALOX15B_uc010cnp.3_5'UTR NM_001141 NP_001132 O15296 LX15B_HUMAN Homo sapiens arachidonate 15-lipoxygenase, type B (ALOX15B), transcript variant d, mRNA. 2 PLAT. induction of apoptosis|leukotriene biosynthetic process|negative regulation of cell cycle|negative regulation of cell migration|negative regulation of cell proliferation|negative regulation of growth|prostate gland development|regulation of epithelial cell differentiation cytoplasm arachidonate 15-lipoxygenase activity|iron ion binding|lipoxygenase activity NS(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(5)|lung(3)|ovary(1)|prostate(2)|skin(2)|stomach(4)|upper_aerodigestive_tract(1) 24 GCAGCATGGCCGAGTTCAGGG 0.652 UBC 7316 broad.mit.edu 37 17 21731124 21731124 + Silent SNP C C A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:21731124C>A uc002gyy.3 + 1 551 c.426C>A c.(424-426)acC>acA p.T142T P0CG48 UBC_HUMAN SubName: Full=Uncharacterized protein; 294 Ubiquitin-like 2. activation of MAPK activity|anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|anti-apoptosis|apoptosis|cellular membrane organization|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA repair|endosome transport|epidermal growth factor receptor signaling pathway|G1/S transition of mitotic cell cycle|I-kappaB kinase/NF-kappaB cascade|induction of apoptosis by extracellular signals|innate immune response|JNK cascade|M/G1 transition of mitotic cell cycle|mRNA metabolic process|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of epidermal growth factor receptor signaling pathway|negative regulation of type I interferon production|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|nerve growth factor receptor signaling pathway|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|S phase of mitotic cell cycle|stress-activated MAPK cascade|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway|viral reproduction cytosol|endocytic vesicle membrane|endosome membrane|nucleoplasm|plasma membrane protein binding breast(3)|endometrium(4)|kidney(4)|large_intestine(2)|lung(13)|ovary(3)|prostate(4)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 36 all_neural(191;0.101)|Medulloblastoma(191;0.163) OV - Ovarian serous cystadenocarcinoma(86;6.17e-05)|Epithelial(86;0.000207)|all cancers(50;0.00308) AAGAGTCGACCCTGCATCTGG 0.567 BPTF 2186 broad.mit.edu 37 17 65924656 65924656 + Silent SNP A A G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr17:65924656A>G uc002jgf.3 + 15 5998 c.5937A>G c.(5935-5937)caA>caG p.Q1979Q BPTF_uc002jge.3_Silent_p.Q2105Q NM_182641 NP_872579 Q12830 BPTF_HUMAN Homo sapiens bromodomain PHD finger transcription factor (BPTF), transcript variant 1, mRNA. 2105 brain development|chromatin remodeling|negative regulation of transcription from RNA polymerase II promoter|positive regulation of transcription, DNA-dependent|transcription, DNA-dependent cytoplasm|NURF complex sequence-specific DNA binding|transcription factor binding|zinc ion binding NS(1)|breast(1)|central_nervous_system(3)|cervix(1)|endometrium(11)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(16)|lung(23)|ovary(3)|pancreas(2)|prostate(4)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(2) 78 all_cancers(12;6e-11) BRCA - Breast invasive adenocarcinoma(8;7.48e-08)|Colorectal(3;0.0984)|LUSC - Lung squamous cell carcinoma(166;0.24) TAACATTCCAACAAAACAAGA 0.393 CATSPERD 257062 broad.mit.edu 37 19 5739352 5739352 + Missense_Mutation SNP G G C TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr19:5739352G>C uc002mda.3 + 6 536 c.475G>C c.(475-477)Gtt>Ctt p.V159L CATSPERD_uc010duj.1_5'UTR NM_152784 NP_689997 Q86XM0 TM146_HUMAN Homo sapiens transmembrane protein 146 (TMEM146), mRNA. 159 integral to membrane CAGTAATTTGGTTTTTGCATA 0.338 MUC16 94025 broad.mit.edu 37 19 9049260 9049260 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr19:9049260G>A uc002mkp.3 - 4 32575 c.32371C>T c.(32371-32373)Cgg>Tgg p.R10791W NM_024690 NP_078966 Q8WXI7 MUC16_HUMAN Homo sapiens mucin 16, cell surface associated (MUC16), mRNA. 10793 Thr-rich. cell adhesion extracellular space|extrinsic to membrane|integral to membrane|plasma membrane protein binding NS(9)|autonomic_ganglia(1)|breast(26)|central_nervous_system(11)|cervix(1)|endometrium(46)|haematopoietic_and_lymphoid_tissue(5)|kidney(35)|large_intestine(91)|liver(1)|lung(278)|ovary(17)|pancreas(2)|prostate(17)|skin(18)|soft_tissue(1)|stomach(8)|upper_aerodigestive_tract(16)|urinary_tract(7) 590 GTCACCAACCGTGATACAGCA 0.483 CASP14 23581 broad.mit.edu 37 19 15164396 15164396 + Missense_Mutation SNP G G T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr19:15164396G>T uc010dzv.2 + 2 343 c.131G>T c.(130-132)cGg>cTg p.R44L NM_012114 NP_036246 P31944 CASPE_HUMAN Homo sapiens caspase 14, apoptosis-related cysteine peptidase (CASP14), mRNA. 44 apoptosis|cell differentiation|epidermis development|proteolysis cytoplasm|nucleus cysteine-type endopeptidase activity p.R44Q(2)|p.R44W(1) NS(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(9)|lung(8)|ovary(1)|prostate(1)|skin(3) 26 CACATGTTTCGGCAGCTGAGA 0.527 PPFIA3 8541 broad.mit.edu 37 19 49651354 49651354 + Silent SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr19:49651354C>T uc002pmr.3 + 23 3182 c.2850C>T c.(2848-2850)ggC>ggT p.G950G PPFIA3_uc010yai.2_Non-coding_Transcript|PPFIA3_uc002pms.3_Silent_p.G809G|PPFIA3_uc002pmt.3_Silent_p.G89G|PPFIA3_uc002pmu.1_5'UTR NM_003660 NP_003651 O75145 LIPA3_HUMAN Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 (PPFIA3), mRNA. 950 cell surface|cytoplasm protein binding NS(1)|breast(1)|cervix(1)|endometrium(2)|kidney(1)|large_intestine(4)|liver(2)|lung(16)|pancreas(1)|prostate(1)|skin(4)|urinary_tract(1) 35 all_lung(116;3.16e-06)|Lung NSC(112;6.25e-06)|all_neural(266;0.0189)|Ovarian(192;0.0392) all cancers(93;2.36e-05)|OV - Ovarian serous cystadenocarcinoma(262;0.000203)|GBM - Glioblastoma multiforme(486;0.00307)|Epithelial(262;0.00677) TGGCATATGGCGACATGAACC 0.617 KLF11 8462 broad.mit.edu 37 2 10188462 10188462 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr2:10188462C>T uc002raf.1 + 2 1160 c.998C>T c.(997-999)gCt>gTt p.A333V KLF11_uc021vdq.1_Missense_Mutation_p.A316V|KLF11_uc010yjc.2_Missense_Mutation_p.A316V NM_003597 NP_001171189 O14901 KLF11_HUMAN Homo sapiens Kruppel-like factor 11 (KLF11), transcript variant 1, mRNA. 333 apoptosis|negative regulation of cell proliferation|negative regulation of transcription from RNA polymerase II promoter|positive regulation of apoptosis|regulation of transcription involved in S phase of mitotic cell cycle nucleus sequence-specific DNA binding RNA polymerase II transcription factor activity|transcription regulatory region DNA binding|zinc ion binding endometrium(2)|kidney(1)|large_intestine(2)|lung(5)|ovary(3)|prostate(1)|skin(1)|upper_aerodigestive_tract(1) 16 all_hematologic(175;0.127)|Acute lymphoblastic leukemia(172;0.155) Epithelial(75;0.133)|OV - Ovarian serous cystadenocarcinoma(76;0.228) GTGGGACCTGCTGTGCCTCAG 0.622 OREG0014425 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) ACTG2 72 broad.mit.edu 37 2 74140711 74140711 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr2:74140711G>A uc002sjw.3 + 5 673 c.551G>A c.(550-552)cGt>cAt p.R184H ACTG2_uc010yrn.2_Missense_Mutation_p.R141H|ACTG2_uc010fey.3_Missense_Mutation_p.R184H NM_001615 NP_001606 P63267 ACTH_HUMAN Homo sapiens actin, gamma 2, smooth muscle, enteric (ACTG2), transcript variant 1, mRNA. 184 muscle contraction cytoskeleton|cytosol ATP binding large_intestine(3)|lung(14)|skin(1) 18 TTGGCTGGCCGTGACCTCACG 0.552 VIL1 7429 broad.mit.edu 37 2 219301877 219301877 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr2:219301877G>A uc002vib.3 + 15 2024 c.2002G>A c.(2002-2004)Gag>Aag p.E668K VIL1_uc010zke.2_Missense_Mutation_p.E357K|VIL1_uc002via.3_Missense_Mutation_p.E668K NM_007127 NP_009058 P09327 VILI_HUMAN Homo sapiens villin 1 (VIL1), mRNA. 668 Core. actin filament capping|actin filament depolymerization|actin filament polymerization|actin filament severing|apoptosis|cellular response to epidermal growth factor stimulus|cytoplasmic actin-based contraction involved in cell motility|epidermal growth factor receptor signaling pathway|positive regulation of actin filament bundle assembly|positive regulation of epithelial cell migration|regulation of actin nucleation|regulation of cell shape|regulation of lamellipodium morphogenesis|regulation of wound healing|response to bacterium actin filament bundle|cytoplasm|filopodium tip|intracellular membrane-bounded organelle|lamellipodium|microvillus|ruffle actin filament binding|calcium ion binding|caspase inhibitor activity|lysophosphatidic acid binding|phosphatidylinositol-4,5-bisphosphate binding|protein homodimerization activity NS(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(4)|lung(20)|ovary(2)|prostate(3)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1) 41 Renal(207;0.0474) Epithelial(149;6.88e-07)|all cancers(144;0.00013)|LUSC - Lung squamous cell carcinoma(224;0.008)|Lung(261;0.00942) ACATGCCAACGAGGAGGAGAA 0.577 PDYN 5173 broad.mit.edu 37 20 1961151 1961151 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr20:1961151C>T uc010gaj.3 - 2 825 c.583G>A c.(583-585)Ggg>Agg p.G195R AK090681_uc002wfu.1_Intron|PDYN_uc021vzs.1_Missense_Mutation_p.G195R|PDYN_uc021vzt.1_Missense_Mutation_p.G195R|PDYN_uc021vzu.1_Missense_Mutation_p.G195R|PDYN_uc002wfv.3_Missense_Mutation_p.G195R NM_001190892 NP_077722 P01213 PDYN_HUMAN Homo sapiens prodynorphin (PDYN), transcript variant 3, mRNA. 195 cell death|neuropeptide signaling pathway|synaptic transmission extracellular region|plasma membrane opioid peptide activity p.D194E(1) endometrium(3)|kidney(1)|large_intestine(5)|lung(22)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1) 38 ATGCTATCCCCGTCCCCCTCC 0.597 RALGAPA2 57186 broad.mit.edu 37 20 20493649 20493649 + Missense_Mutation SNP G G C TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr20:20493649G>C uc002wrz.3 - 31 4507 c.4364C>G c.(4363-4365)tCt>tGt p.S1455C RALGAPA2_uc002wry.3_Missense_Mutation_p.S1070C|RALGAPA2_uc010zsg.2_Missense_Mutation_p.S903C|RALGAPA2_uc002wsa.1_Missense_Mutation_p.S227C NM_020343 NP_065076 Q2PPJ7 RGPA2_HUMAN Homo sapiens Ral GTPase activating protein, alpha subunit 2 (catalytic) (RALGAPA2), mRNA. 1455 activation of Ral GTPase activity cytosol|nucleus protein heterodimerization activity|Ral GTPase activator activity endometrium(14)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(6)|liver(1)|lung(25)|ovary(1)|prostate(1)|upper_aerodigestive_tract(1) 54 ATCAGAGAGAGAGCCCACTGG 0.478 RALGAPB 57148 broad.mit.edu 37 20 37182634 37182634 + Missense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr20:37182634G>A uc002xiw.3 + 21 3544 c.3287G>A c.(3286-3288)tGc>tAc p.C1096Y RALGAPB_uc002xix.3_Missense_Mutation_p.C1092Y|RALGAPB_uc002xiy.1_Intron|RALGAPB_uc002xiz.3_Missense_Mutation_p.C874Y NM_020336 NP_065069 Q86X10 RLGPB_HUMAN Homo sapiens Ral GTPase activating protein, beta subunit (non-catalytic) (RALGAPB), mRNA. 1096 activation of Ral GTPase activity intracellular protein heterodimerization activity|Ral GTPase activator activity breast(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(8)|lung(29)|ovary(1)|pancreas(1)|prostate(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(2) 65 GTTACGGATTGCAAGCCCCCG 0.478 LAMA5 3911 broad.mit.edu 37 20 60911477 60911477 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr20:60911477C>T uc002ycq.3 - 17 2309 c.2242G>A c.(2242-2244)Gct>Act p.A748T LAMA5_uc021wfw.1_Missense_Mutation_p.A748T NM_005560 NP_005551 O15230 LAMA5_HUMAN Homo sapiens laminin, alpha 5 (LAMA5), mRNA. 748 Laminin EGF-like 9. angiogenesis|cell proliferation|cell recognition|cytoskeleton organization|endothelial cell differentiation|focal adhesion assembly|integrin-mediated signaling pathway|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|substrate adhesion-dependent cell spreading extracellular space|laminin-1 complex|laminin-10 complex|laminin-11 complex integrin binding breast(2)|central_nervous_system(3)|cervix(1)|endometrium(6)|haematopoietic_and_lymphoid_tissue(3)|kidney(7)|lung(40)|ovary(1)|pancreas(1)|prostate(3)|skin(6)|stomach(1)|upper_aerodigestive_tract(5)|urinary_tract(2) 81 Breast(26;1.57e-08) BRCA - Breast invasive adenocarcinoma(19;4.36e-06) Alteplase(DB00009)|Anistreplase(DB00029)|Reteplase(DB00015)|Tenecteplase(DB00031) TCCACGTGAGCCCGGCACATA 0.642 APOBEC3F 200316 broad.mit.edu 37 22 39448100 39448100 + Missense_Mutation SNP C C A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr22:39448100C>A uc021wpr.1 + APOBEC3F_uc003aww.3_Missense_Mutation_p.H249N NM_021822 NP_068594 Q9HC16 ABC3G_HUMAN Homo sapiens apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G), mRNA. base conversion or substitution editing|DNA cytosine deamination|innate immune response|interspecies interaction between organisms|negative regulation of retroviral genome replication|negative regulation of transposition|positive regulation of defense response to virus by host|response to virus|viral reproduction apolipoprotein B mRNA editing enzyme complex|cytosol|mitochondrion cytidine deaminase activity|dCTP deaminase activity|protein homodimerization activity|RNA binding|zinc ion binding breast(3)|endometrium(1)|kidney(1)|large_intestine(3)|lung(6)|skin(2) 16 Melanoma(58;0.04) GACCCATTGTCATGCAGAAAG 0.572 RPL14 9045 broad.mit.edu 37 3 40499407 40499407 + Silent SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr3:40499407C>T uc003ckg.3 + 1 81 c.30C>T c.(28-30)ggC>ggT p.G10G RPL14_uc003ckh.3_Silent_p.G10G NM_003973 NP_003964 P50914 RL14_HUMAN Homo sapiens ribosomal protein L14 (RPL14), transcript variant 2, mRNA. 10 endocrine pancreas development|ribosomal large subunit biogenesis|rRNA processing|translational elongation|translational termination|viral transcription cytosolic large ribosomal subunit protein binding|RNA binding|structural constituent of ribosome KIRC - Kidney renal clear cell carcinoma(284;0.0517)|Kidney(284;0.065) TGGAGGTTGGCCGGGTGGCCT 0.443 CDCP1 64866 broad.mit.edu 37 3 45127459 45127459 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr3:45127459C>T uc003com.3 - 8 2317 c.2182G>A c.(2182-2184)Gac>Aac p.D728N NM_022842 NP_073753 Q9H5V8 CDCP1_HUMAN Homo sapiens CUB domain containing protein 1 (CDCP1), transcript variant 1, mRNA. 728 extracellular region|integral to membrane|plasma membrane central_nervous_system(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(3)|lung(12)|ovary(1)|skin(4)|urinary_tract(1) 29 BRCA - Breast invasive adenocarcinoma(193;0.00928)|KIRC - Kidney renal clear cell carcinoma(197;0.0519)|Kidney(197;0.0651) GAGTCATTGTCCTTTCGCCCT 0.502 SLC15A2 6565 broad.mit.edu 37 3 121641692 121641692 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr3:121641692C>T uc003eep.2 + 8 1004 c.851C>T c.(850-852)gCg>gTg p.A284V SLC15A2_uc011bjn.1_Missense_Mutation_p.A253V NM_021082 NP_066568 Q16348 S15A2_HUMAN Homo sapiens solute carrier family 15 (H+/peptide transporter), member 2 (SLC15A2), transcript variant 1, mRNA. 284 protein transport integral to plasma membrane peptide:hydrogen symporter activity|protein binding NS(1)|endometrium(1)|kidney(4)|large_intestine(5)|lung(17)|skin(6)|upper_aerodigestive_tract(2) 36 GBM - Glioblastoma multiforme(114;0.0967) Cefadroxil(DB01140) CTAGACTGGGCGGCTGAGAAA 0.433 ILDR1 286676 broad.mit.edu 37 3 121712145 121712145 + Missense_Mutation SNP T T G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr3:121712145T>G uc003ees.3 - 6 1654 c.1451A>C c.(1450-1452)gAc>gCc p.D484A ILDR1_uc003eeq.3_Missense_Mutation_p.D452A|ILDR1_uc003eer.3_Missense_Mutation_p.D440A|ILDR1_uc010hrg.3_Missense_Mutation_p.D395A NM_001199799 NP_001186728 Q86SU0 ILDR1_HUMAN Homo sapiens immunoglobulin-like domain containing receptor 1 (ILDR1), transcript variant 1, mRNA. 484 cytosol|integral to membrane|plasma membrane receptor activity central_nervous_system(1)|endometrium(4)|kidney(1)|large_intestine(10)|lung(4)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1) 25 GBM - Glioblastoma multiforme(114;0.156) CCTCTCCTTGTCCTCTTCAGA 0.677 PIK3CA 5290 broad.mit.edu 37 3 178938803 178938803 + Frame_Shift_Del DEL A A - TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr3:178938803delA uc003fjk.3 + 13 2202 c.2045delA c.(2044-2046)cagfs p.Q682fs NM_006218 NP_006209 P42336 PK3CA_HUMAN Homo sapiens phosphoinositide-3-kinase, catalytic, alpha polypeptide (PIK3CA), mRNA. 682 PI3K helical. epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway 1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208) 5269 all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155) OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282) ACAGTTAGCCAGAGGTTTGGC 0.348 57 Mis """colorectal, gastric, gliobastoma, breast""" HNSCC(19;0.045)|TSP Lung(28;0.18) HTRA3 94031 broad.mit.edu 37 4 8307709 8307709 + Missense_Mutation SNP A A G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr4:8307709A>G uc003gla.3 + 8 1415 c.1208A>G c.(1207-1209)cAa>cGa p.Q403R NM_053044 NP_444272 P83110 HTRA3_HUMAN Homo sapiens HtrA serine peptidase 3 (HTRA3), mRNA. 403 PDZ. proteolysis|regulation of cell growth extracellular region insulin-like growth factor binding|serine-type endopeptidase activity central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(2)|liver(1)|lung(6)|ovary(2)|prostate(1)|urinary_tract(1) 18 GGCGGCATCCAAGATGGTGAC 0.647 N4BP2 55728 broad.mit.edu 37 4 40127847 40127847 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr4:40127847C>T uc003guy.4 + 11 4762 c.4424C>T c.(4423-4425)tCt>tTt p.S1475F N4BP2_uc010ifq.3_Missense_Mutation_p.S1395F|N4BP2_uc010ifr.3_Missense_Mutation_p.S1395F NM_018177 NP_060647 Q86UW6 N4BP2_HUMAN Homo sapiens NEDD4 binding protein 2 (N4BP2), mRNA. 1475 cytoplasm ATP binding|ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity|endonuclease activity|protein binding breast(4)|endometrium(3)|kidney(12)|large_intestine(7)|liver(2)|lung(22)|ovary(1)|pancreas(1)|prostate(2)|skin(5)|upper_aerodigestive_tract(1) 60 TTAACAGCATCTGAAATGCTA 0.338 NAA11 84779 broad.mit.edu 37 4 80246554 80246554 + Nonsense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr4:80246554G>A uc003hlt.4 - 0 618 c.478C>T c.(478-480)Cga>Tga p.R160* NAA11_uc021xpl.1_Nonsense_Mutation_p.R160* NM_032693 NP_116082 Q9BSU3 NAA11_HUMAN Homo sapiens N(alpha)-acetyltransferase 11, NatA catalytic subunit (NAA11), mRNA. 160 cytoplasm|nucleus peptide alpha-N-acetyltransferase activity|protein binding p.R159K(1) NS(1)|breast(1)|central_nervous_system(1)|endometrium(3)|large_intestine(4)|lung(9)|ovary(1)|pancreas(1)|skin(2) 23 TCCATTTGTCGTCTCAGCTCA 0.517 ANKRD50 57182 broad.mit.edu 37 4 125591834 125591834 + Silent SNP A A G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr4:125591834A>G uc010inw.3 - 3 3636 c.2598T>C c.(2596-2598)ctT>ctC p.L866L ANKRD50_uc011cgo.2_Silent_p.L687L NM_020337 NP_001161354 Q9ULJ7 ANR50_HUMAN Homo sapiens ankyrin repeat domain 50 (ANKRD50), transcript variant 1, mRNA. 866 NS(1)|breast(3)|central_nervous_system(1)|endometrium(7)|kidney(4)|large_intestine(14)|lung(18)|prostate(4)|skin(2)|upper_aerodigestive_tract(1) 55 CTTGTTCAATAAGTGCTTCAC 0.393 NEIL3 55247 broad.mit.edu 37 4 178274739 178274739 + Missense_Mutation SNP T T G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr4:178274739T>G uc003iut.2 + 7 1434 c.1317T>G c.(1315-1317)gaT>gaG p.D439E NEIL3_uc010irs.3_3'UTR NM_018248 NP_060718 Q8TAT5 NEIL3_HUMAN Homo sapiens nei endonuclease VIII-like 3 (E. coli) (NEIL3), mRNA. 439 base-excision repair|nucleotide-excision repair nucleus bubble DNA binding|damaged DNA binding|DNA N-glycosylase activity|DNA-(apurinic or apyrimidinic site) lyase activity|double-stranded DNA binding|single-stranded DNA binding|zinc ion binding breast(1)|central_nervous_system(1)|endometrium(3)|kidney(1)|large_intestine(4)|lung(14)|ovary(1)|prostate(1)|upper_aerodigestive_tract(2)|urinary_tract(1) 29 Breast(14;6.27e-05)|Melanoma(52;0.00102)|Renal(120;0.00988)|Prostate(90;0.00996)|all_hematologic(60;0.014)|all_neural(102;0.164) all cancers(43;1.96e-23)|Epithelial(43;2.52e-20)|OV - Ovarian serous cystadenocarcinoma(60;1.89e-11)|GBM - Glioblastoma multiforme(59;9.49e-05)|Colorectal(24;0.00013)|COAD - Colon adenocarcinoma(29;0.000696)|STAD - Stomach adenocarcinoma(60;0.00308)|LUSC - Lung squamous cell carcinoma(193;0.0398)|READ - Rectum adenocarcinoma(43;0.191) CAACAAACGATATAACTCAAC 0.373 Base excision repair (BER), DNA glycosylases SDHAP3 728609 broad.mit.edu 37 5 1593264 1593264 + Missense_Mutation SNP C C T rs111700178 by1000genomes TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr5:1593264C>T uc010itg.1 - 1 273 c.196G>A c.(196-198)Gca>Aca p.A66T SDHAP3_uc011cme.2_Non-coding_Transcript Homo sapiens succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 3 (SDHAP3), non-coding RNA. AGGGCACATGCCTGACCAAAG 0.557 ATG12 9140 broad.mit.edu 37 5 115177234 115177234 + Nonsense_Mutation SNP G G A TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr5:115177234G>A uc003krh.3 - 0 315 c.16C>T c.(16-18)Cag>Tag p.Q6* AP3S1_uc003krl.3_5'Flank|AP3S1_uc003krk.3_5'Flank|ATG12_uc021ycr.1_Non-coding_Transcript|ATG12_uc021ycs.1_Non-coding_Transcript|ATG12_uc003kri.3_Nonsense_Mutation_p.Q53* NM_004707 NP_004698 O94817 ATG12_HUMAN Homo sapiens ATG12 autophagy related 12 homolog (S. cerevisiae) (ATG12), transcript variant 1, mRNA. 6 autophagic vacuole assembly|negative regulation of type I interferon production pre-autophagosomal structure membrane protein binding endometrium(2)|kidney(1)|lung(1)|prostate(1) 5 all_cancers(142;0.00377)|all_epithelial(76;0.000129)|Prostate(80;0.0132)|Ovarian(225;0.0776)|Lung NSC(810;0.245) OV - Ovarian serous cystadenocarcinoma(64;7.59e-08)|Epithelial(69;7.05e-07)|all cancers(49;3.11e-05) AACACAGACTGCGGCTCCTCC 0.607 PCDHB10 56126 broad.mit.edu 37 5 140573541 140573541 + Silent SNP C C T rs17844565 byFrequency TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr5:140573541C>T uc003lix.3 + 0 1590 c.1416C>T c.(1414-1416)agC>agT p.S472S NM_018930 NP_061753 Q9UN67 PCDBA_HUMAN Homo sapiens protocadherin beta 10 (PCDHB10), mRNA. 472 Cadherin 5. calcium-dependent cell-cell adhesion|homophilic cell adhesion|synapse assembly|synaptic transmission integral to membrane|plasma membrane calcium ion binding p.S472S(2) breast(3)|endometrium(5)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(14)|lung(30)|ovary(4)|prostate(5)|skin(3)|upper_aerodigestive_tract(4)|urinary_tract(2) 76 KIRC - Kidney renal clear cell carcinoma(527;0.00185)|Kidney(363;0.00339) ACATCGGCAGCGTCAGCGCCA 0.662 ZUFSP 221302 broad.mit.edu 37 6 116987896 116987896 + Missense_Mutation SNP G G T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr6:116987896G>T uc003pxf.2 - 1 720 c.460C>A c.(460-462)Cct>Act p.P154T ZUFSP_uc010kef.2_Intron NM_145062 NP_659499 Q96AP4 ZUFSP_HUMAN Homo sapiens zinc finger with UFM1-specific peptidase domain (ZUFSP), mRNA. 154 intracellular zinc ion binding NS(1)|endometrium(2)|kidney(6)|large_intestine(1)|lung(6)|pancreas(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(2) 21 GBM - Glioblastoma multiforme(226;0.0258)|all cancers(137;0.0368)|OV - Ovarian serous cystadenocarcinoma(136;0.0464)|Epithelial(106;0.186) GGACATTCAGGAGGACTGTAT 0.378 LAMA2 3908 broad.mit.edu 37 6 129573419 129573419 + Missense_Mutation SNP T T C TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr6:129573419T>C uc021zfb.1 + 13 2180 c.2075T>C c.(2074-2076)tTt>tCt p.F692S LAMA2_uc003qbn.3_Missense_Mutation_p.F692S|LAMA2_uc003qbo.3_Missense_Mutation_p.F692S NM_000426 NP_000417 P24043 LAMA2_HUMAN Homo sapiens laminin, alpha 2 (LAMA2), transcript variant 1, mRNA. 692 Laminin IV type A 1. cell adhesion|muscle organ development|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development laminin-1 complex receptor binding|structural molecule activity NS(2)|biliary_tract(2)|breast(10)|central_nervous_system(1)|endometrium(18)|haematopoietic_and_lymphoid_tissue(2)|kidney(7)|large_intestine(35)|lung(84)|ovary(10)|prostate(4)|skin(9)|stomach(1)|upper_aerodigestive_tract(7)|urinary_tract(2) 194 OV - Ovarian serous cystadenocarcinoma(136;0.178)|all cancers(137;0.245) ACATACAGCTTTGGGATGGAT 0.453 PLXNA4 91584 broad.mit.edu 37 7 131982916 131982916 + Silent SNP G G T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr7:131982916G>T uc003vra.4 - 3 1666 c.1437C>A c.(1435-1437)ggC>ggA p.G479G NM_020911 NP_065962 Q9HCM2 PLXA4_HUMAN Homo sapiens plexin A4 (PLXNA4), transcript variant 1, mRNA. 479 Sema. integral to membrane|intracellular|plasma membrane NS(1)|breast(1)|endometrium(3)|kidney(4)|large_intestine(14)|lung(17)|ovary(1)|prostate(2)|skin(1)|stomach(1) 45 GGAGGACTGGGCCGGGGTCCA 0.582 DLGAP2 9228 broad.mit.edu 37 8 1574988 1574988 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr8:1574988C>T uc003wpl.3 + 3 1382 c.1285C>T c.(1285-1287)Cgc>Tgc p.R429C DLGAP2_uc003wpm.3_Missense_Mutation_p.R429C NM_004745 NP_004736 Q9P1A6 DLGP2_HUMAN Homo sapiens discs, large (Drosophila) homolog-associated protein 2 (DLGAP2), mRNA. 508 neuron-neuron synaptic transmission cell junction|neurofilament|postsynaptic density|postsynaptic membrane protein binding breast(1)|endometrium(6)|lung(31)|prostate(3) 41 Ovarian(12;0.0271)|Hepatocellular(245;0.0838)|Colorectal(14;0.0846) BRCA - Breast invasive adenocarcinoma(11;0.000169)|READ - Rectum adenocarcinoma(644;0.171) CCCGAAATTCCGCTCCCGGAA 0.617 MPDZ 8777 broad.mit.edu 37 9 13162794 13162794 + Silent SNP T T C TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chr9:13162794T>C uc010mia.1 - 22 3312 c.3255_splice c.e22-1 p.K1085_splice MPDZ_uc010mhx.3_Splice_Site|MPDZ_uc011lmm.2_Splice_Site|MPDZ_uc003zkz.4_Intron|MPDZ_uc010mhz.3_Splice_Site_p.K1085_splice|MPDZ_uc011lmn.2_Splice_Site_p.K1085_splice|MPDZ_uc010mhy.3_Splice_Site_p.K1085_splice|MPDZ_uc003zlb.4_Splice_Site_p.K1085_splice NM_003829 NP_003820 O75970 MPDZ_HUMAN Homo sapiens multiple PDZ domain protein (MPDZ), mRNA. 1085 PDZ 6. interspecies interaction between organisms apical plasma membrane|dendrite|postsynaptic density|postsynaptic membrane|synaptosome|tight junction protein C-terminus binding NS(1)|breast(2)|central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(4)|kidney(2)|large_intestine(14)|lung(15)|ovary(5)|prostate(7)|stomach(1)|urinary_tract(2) 61 GBM - Glioblastoma multiforme(50;2.03e-06) CATAAGTAATTCTGGAACAAA 0.348 DCAF12L1 139170 broad.mit.edu 37 X 125685588 125685588 + Missense_Mutation SNP C C T TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chrX:125685588C>T uc022cds.1 - 0 1004 c.1004G>A c.(1003-1005)cGc>cAc p.R335H DCAF12L1_uc004eul.3_Missense_Mutation_p.R335H NM_178470 NP_848565 Q5VU92 DC121_HUMAN Homo sapiens DDB1 and CUL4 associated factor 12-like 1 (DCAF12L1), mRNA. 335 breast(1)|central_nervous_system(3)|cervix(1)|endometrium(4)|kidney(3)|large_intestine(6)|lung(39)|ovary(2)|prostate(1)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2) 68 CTGGTCCTGGCGCAGATCCAG 0.597 VAMP7 6845 broad.mit.edu 37 X 155169439 155169439 + Missense_Mutation SNP C C G TCGA-76-6193-01A-11D-1696-08 TCGA-76-6193-10A-01D-1696-08 Untested Somatic Phase_I WXS none Illumina GAIIx 6a751d65-5fcf-4c03-8253-8f1b8faccab2 2c173733-933e-408a-b54b-ded5dffc589e g.chrX:155169439C>G uc004fnr.3 + 6 754 c.576C>G c.(574-576)atC>atG p.I192M VAMP7_uc011naa.2_Missense_Mutation_p.I153M|VAMP7_uc011nab.2_Missense_Mutation_p.I91M|VAMP7_uc004fnt.3_Missense_Mutation_p.I151M|VAMP7_uc004fns.3_Missense_Mutation_p.H170D|VAMP7_uc011nac.2_Missense_Mutation_p.I125M NM_005638 NP_005629 P51809 VAMP7_HUMAN Homo sapiens vesicle-associated membrane protein 7 (VAMP7), transcript variant 1, mRNA. 192 calcium ion-dependent exocytosis|endosome to lysosome transport|eosinophil degranulation|ER to Golgi vesicle-mediated transport|neutrophil degranulation|phagocytosis, engulfment|post-Golgi vesicle-mediated transport|protein transport|vesicle fusion endoplasmic reticulum membrane|Golgi apparatus|integral to membrane|late endosome membrane|lysosomal membrane|phagocytic vesicle membrane|plasma membrane|SNARE complex|transport vesicle membrane protein binding large_intestine(1)|lung(8) 9 all_cancers(53;1.86e-17)|all_epithelial(53;2.71e-11)|all_lung(58;1.84e-07)|Lung NSC(58;5.62e-07)|all_hematologic(71;2.45e-06)|Acute lymphoblastic leukemia(192;6.56e-05)|Breast(217;0.176)|Renal(33;0.214) TCACTATTATCATCATCATCG 0.333